Show simple item record

dc.creatorPérez C,Carlos
dc.creatorErrázuriz C,Isabel
dc.creatorBrockmann V,Pablo
dc.creatorGonzález B,Sergio
dc.creatorCofré L,Cecilia
dc.date2003-01-01
dc.date.accessioned2019-09-10T12:42:57Z
dc.date.available2019-09-10T12:42:57Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000100013
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/107439
dc.descriptionA 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms (Rev Méd Chile 2003; 131: 81-84)
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872003000100013
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.131 n.1 2003
dc.subjectEosinophilic granuloma
dc.subjectInflammatory bowel diseases
dc.subjectMesalazine
dc.subjectPulmonary eosinophilia
dc.titleNeumonía eosinofílica inducida por mesalazina: Caso clínico


This item appears in the following Collection(s)

Show simple item record